Sarilumab comment watch save
BreastfeedingGeriatricPediatric

  • FDA APPROVAL DATE: 05/22/2017
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Live vaccines
  • PREGNANCY: Based on animal data, may cause fetal harm

Investigated for treating COVID-19.

RISK OF SERIOUS INFECTIONS

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 08/20/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top